The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Small renal masses progressing to metastases under active surveillance: A systematic review and pooled analysis
Open accessAbstract
BACKGROUND: The authors systematically reviewed the literature and conducted a pooled analysis of studies on small renal masses who underwent active surveillance to identify the risk progression and the characteristics associated with metastases. METHODS: A search of the MEDLINE database was performed to identify all clinical series that reported the surveillance of localized renal masses. For studies that reported individual‐level data, clinical and radiographic characteristics of tumors without progression were compared with the characteristics of tumors that progressed to metastases. RESULTS: Eighteen series (880 patients, 936 masses) met screening criteria; and, among these, 18 patients were identified who had tumors that progressed to metastasis (mean, 40.2 months). Six studies (259 patients, 284 masses) provided individual‐level data for pooled analysis. At a mean (±standard deviation) follow‐up of 33.5 ± 22.6 months, the mean initial greatest tumor dimension was 2.3 ± 1.3 cm, and mean linear growth rate was 0.31 ± 0.38 cm per year. Sixty‐five masses (23%) exhibited zero net growth under surveillance, and none of those masses progressed to metastasis. A pooled analysis revealed increased age (age 75.1 ± 9.1 years vs 66.6 ± 12.3 years; P = .03), an initial greatest tumor dimension (4.1 ± 2.1 cm vs 2.3 ± 1.3 cm; P < .0001), initial estimated tumor volume (66.3 ± 100.0 cm 3 vs 15.1 ± 60.3 cm 3; p = .0001), linear growth rate of (0.8 ± 0.65 cm per year vs 0.3 ± 0.4 cm per year; P = .0001), and a volumetric growth rate of 27.1 ± 24.9 cm 3 per year (vs 6.2 ± 27.5 cm 3 per year; P < .0001) in the progression cohort. CONCLUSIONS: A substantial proportion of small renal masses remained radiographically static after an initial period of active surveillance. Progression to metastases occurred in a small percentage of patients and generally was a late event. The current results indicated that, in patients who have competing health risks, radiographic surveillance may be an acceptable initial approach, and delayed intervention may be reserved for patients who have tumors that exhibit significant linear or volumetric growth. Cancer 2012;. © 2011 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,188
Investigating and dealing with publication and other biases in meta-analysis
Sterne, J. A. C., Egger, M., & Smith, G. D. (2001) · BMJ · doi:10.1136/bmj.323.7304.101 · Cited by 2,225
Guideline for Management of the Clinical T1 Renal Mass
Campbell, S. C., Novick, A. C., Belldegrun, A., Blute, M. L., Chow, G. K., Derweesh, I. H., Faraday, M. M., Kaouk, J. H., Leveillee, R. J., Matin, S. F., et al. (2009) · Journal of Urology · doi:10.1016/j.juro.2009.07.004 · Cited by 1,831
Self-citationHuang, W. C., Levey, A. S., Serio, A. M., Snyder, M., Vickers, A. J., Raj, G. V., Scardino, P. T., & Russo, P. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70803-8 · Cited by 1,613
Rising Incidence of Renal Cell Cancer in the United States
Chow, W.-H. (1999) · JAMA · doi:10.1001/jama.281.17.1628 · Cited by 1,586
Rising Incidence of Small Renal Masses: A Need to Reassess Treatment Effect
Hollingsworth, J. M., Miller, D. C., Daignault, S., & Hollenbeck, B. K. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj362 · Cited by 1,173
Solid Renal Tumors: An Analysis of Pathological Features Related to Tumor Size
FRANK, I., BLUTE, M. L., CHEVILLE, J. C., LOHSE, C. M., WEAVER, A. L., & ZINCKE, H. (2003) · Journal of Urology · doi:10.1097/01.ju.0000095475.12515.5e · Cited by 1,080
Klotz, L., Zhang, L., Lam, A., Nam, R., Mamedov, A., & Loblaw, A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.2180 · Cited by 1,074
Huang, W. C., Elkin, E. B., Levey, A. S., Jang, T. L., & Russo, P. (2009) · Journal of Urology · doi:10.1016/j.juro.2008.09.017 · Cited by 838
Uses of ecologic analysis in epidemiologic research.
Morgenstern, H. (1982) · American Journal of Public Health · doi:10.2105/ajph.72.12.1336 · Cited by 797
Thompson, R. H., Boorjian, S. A., Lohse, C. M., Leibovich, B. C., Kwon, E. D., Cheville, J. C., & Blute, M. L. (2008) · Journal of Urology · doi:10.1016/j.juro.2007.09.077 · Cited by 713
Natural history of chronic renal insufficiency after partial and radical nephrectomy
McKiernan, J., Simmons, R., Katz, J., & Russo, P. (2002) · Urology · doi:10.1016/s0090-4295(02)01501-7 · Cited by 533
The natural history of incidentally detected small renal masses
Volpe, A., Panzarella, T., Rendon, R. A., Haider, M. A., Kondylis, F. I., & Jewett, M. A. S. (2004) · Cancer · doi:10.1002/cncr.20025 · Cited by 526
Self-citationExcise, Ablate or Observe: The Small Renal Mass Dilemma—A Meta-Analysis and Review
Kunkle, D. A., Egleston, B. L., & Uzzo, R. G. (2008) · Journal of Urology · doi:10.1016/j.juro.2007.11.047 · Cited by 517
Self-citationOn the growth rates of human malignant tumors: Implications for medical decision making
Friberg, S., & Mattson, S. (1997) · Journal of Surgical Oncology · doi:10.1002/(sici)1096-9098(199708)65:4<284::aid-jso11>3.0.co;2-2 · Cited by 346
Hollenbeck, B. K., Taub, D. A., Miller, D. C., Dunn, R. L., & Wei, J. T. (2006) · Urology · doi:10.1016/j.urology.2005.08.050 · Cited by 338
Tumor Size is Associated With Malignant Potential in Renal Cell Carcinoma Cases
Thompson, R. H., Kurta, J. M., Kaag, M., Tickoo, S. K., Kundu, S., Katz, D., Nogueira, L., Reuter, V. E., & Russo, P. (2009) · Journal of Urology · doi:10.1016/j.juro.2009.01.027 · Cited by 295
Kutikov, A., Egleston, B. L., Wong, Y.-N., & Uzzo, R. G. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.4816 · Cited by 292
Self-citationTHE RELATIONSHIP BETWEEN RENAL TUMOR SIZE AND METASTASES IN PATIENTS WITH VON HIPPEL-LINDAU DISEASE
DUFFEY, B. G., CHOYKE, P. L., GLENN, G., GRUBB, R. L., VENZON, D., LINEHAN, W. M., & WALTHER, M. M. (2004) · Journal of Urology · doi:10.1097/01.ju.0000132127.79974.3f · Cited by 216
KATO, M., SUZUKI, T., SUZUKI, Y., TERASAWA, Y., SASANO, H., & ARAI, Y. (2004) · Journal of Urology · doi:10.1097/01.ju.0000136315.80057.99 · Cited by 175
Heuer, R., Gill, I. S., Guazzoni, G. F., Kırkalı, Z., Marberger, M., Richie, J. P., & de la Rosette, J. J. M. C. H. (2009) · European Urology · doi:10.1016/j.eururo.2009.10.023 · Cited by 148
Mues, A. C., & Landman, J. (2010) · Current Opinion in Urology · doi:10.1097/mou.0b013e32833625f8 · Cited by 38
Explaining heterogeneity in meta-analysis: a comparison of methods
Thompson, S. G., & Sharp, S. J. (1999) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19991030)18:20
Cited by
Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline
Finelli, A., Ismaila, N., Bro, B., Durack, J., Eggener, S., Evans, A., Gill, I., Graham, D., Huang, W., Jewett, M. A. S., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.9645 · Cited by 367
Self-citation
Metadata
- Authors
- Smaldone, M. C., Kutikov, A., Egleston, B. L., Canter, D. J., Viterbo, R., Chen, D. Y. T., Jewett, M. A., Greenberg, R. E., & Uzzo, R. G.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2011-07-15
- Volume
- 118
- Issue
- 4
- Pages
- 997-1006
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2034579655
- Cited by
- 405
- References
- 24
- FWCI
- 21.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.